Genmab — Maj 2017

[JKY_VH]

sikkert dage, hvis det er mus

[Raffles]

Tak JKY, det tænker jeg også.

[Darvin]

Tror jeg også

[Fantomas]

Lækker start på dagen

[Her_for_at_lære]

@ E L, you mention "EvaluatePharma 2022 Dara forecast $5.8bn (link)" Any indication of what that isolated would mean for the cap value of Genmap and thereby the shareprice?

[120281]

På min finanzen.net tysk app fik jeg lige en breaking info om Morphosys. Nogen der er bedre til tysk eller der kan finde UK sproget link omkring hvad det er. Mere det ikke er konkurrent til Genmab info, men blot et af deres andre stoffer.

[Darvin]

Her for at lære - så skal du kigge på peaksale 9,4 ifølge samme og alt det andet.

[GeorgeBest]

Morphosys https://www.morphosys.com/media-investors/media-center/morphosys-announces-first-results-from-phase-1-study-with-lanthipeptide

[120281]

Tak @GeorgeBest

[120281]

Umiddelbart ikke noget til farer for Genmab.

[Her_for_at_lære]

@ Darvin tak. Prøver bare at få en ide om udvikling i aktiekursen, som går ud over 12 måneder.

[E_L]

@ Darvin: exactly. think you clarified it better as me.

[E_L]

@ Her for at lære : i rather refer to the analysts for price targets, but my guess is most were lower as the 4bn JNJ now set as their Minimum for 2021 and most are lower as EvaluatePharma.
.

[E_L]

And my targest are higher as most analysts

[bibob]

E L. You are a reel genmabber.

[E_L]

lol, next time people ask me what i do for a living i will say that bibob,
Need to print new business cards

[Her_for_at_lære]

@ EL, thank you

[nohope]

Måske skulle vi søge om at få det registreret som en beskyttet titel ?

[bibob]

E L.

[E_L]

sure, copyright bibob. Maybe we can ask Rachel to get one of their patent lawyers to
take care of that lol